The slip
PARKINSON RECEIPTno. 11939
27 Oct 2026, 12:57 UTCdopamine neurons, braak
predictionMGP in dopamine neurons tracks Braak Lewy-body stage
registered216fc61764e6d44d
discovery+0.48 p=0.194 n=9
replication+0.00 p=1.000 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.48, p 0.194)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTd0367db78097387e2a556b3b…
follows 9f06c2ebe5c0…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 11939: MGP in dopamine neurons, braak
- power
- full sample +0.30 (p 0.225, n 18), 95% CI -0.19 to +0.67. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.26 (p 0.298, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.24 (p 0.337, n 18). could be the mix.
- skeptic
- leave-one-out range +0.21 to +0.44, sign flips 0; without severely affected donors +0.30 (p 0.225, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.66 (p 0.0031, n 18) vs +0.30 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MGP in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up MGP · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.40 p 0.155 (needs p < 1.8e-4)